- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01572961
Microvascular Function Assessment in Healthy Subjects (MICROTEC)
February 11, 2016 updated by: University Hospital, Angers
Amélioration Des Techniques d'étude de la Micro-cirulation cutanée Chez Des Sujets Sains
Current stimulation induces microvascular dilation in human skin.
The investigators aimed to study (1) whether the current vasodilation is amplified after two segmental current stimulation as compared to one stimulation; (2) whether this amplification relies on prostaglandin-sensitive mechanisms.
A double-blind randomized placebo-controlled crossover trial is conducted in Angers, France.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maine et Loire
-
Angers, Maine et Loire, France, 49933
- University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age > or equal to 18 years old
- Healthy subjects
Exclusion Criteria:
- Aspirin allergy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
|
|
Active Comparator: Aspirin
|
single oral dose of 1g.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The increase of Laser Doppler Blood Flow after the second current stimulation
Time Frame: 1 hour
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The increase of Laser Doppler Blood Flow after the second current stimulation after aspirin administration
Time Frame: 1 hour
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Guillaume Mahe, M.D., Ph.D., University Hospital of Angers
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2010
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
May 1, 2013
Study Registration Dates
First Submitted
April 4, 2012
First Submitted That Met QC Criteria
April 5, 2012
First Posted (Estimate)
April 6, 2012
Study Record Updates
Last Update Posted (Estimate)
February 12, 2016
Last Update Submitted That Met QC Criteria
February 11, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Fibrinolytic Agents
- Fibrin Modulating Agents
- Platelet Aggregation Inhibitors
- Cyclooxygenase Inhibitors
- Antipyretics
- Aspirin
Other Study ID Numbers
- 2010-10 (Other Identifier: AP HM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physiology of Microvascular Skin
-
Asian Institute of Gastroenterology, IndiaCompleted
-
National Institute of Neurological Disorders and...CompletedMotor Function of Healthy PhysiologyUnited States
-
Mount St. Mary's College, Los Angeles, CAUnknownPhysiology of Manipulation / Mobilization in Healthy AdultsUnited States
-
Aker Biomarine Antarctic ASAtlantia Food Clinical TrialsUnknown
-
University of ViennaMedical University of ViennaCompletedSkin Physiology | Dermal Administration | EmulsionsAustria
-
Charite University, Berlin, GermanyJohnson & Johnson GmbHCompleted
-
Centre Hospitalier Universitaire de la RéunionUniversité Jean Monnet-Saint-Etienne; Aspetar Orthopedic and Sports Medicine... and other collaboratorsCompleted
-
Radboud University Medical CenterActive, not recruitingCoronary Vasospasm | Microvascular Angina | Microvascular Ischemia of MyocardiumNetherlands
-
National Cancer Institute (NCI)CompletedMenopause | Normal PhysiologyMongolia
-
Johnson & Johnson Vision Care, Inc.Withdrawn
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States